Anavex Life Sciences Corp (AVXL)

[WilliamMunny]

What PDD outcome data on episodic memory are you alluding to? It seems fairly plain to me by the first sentence of that segment ("We (are) now reading out, by the end of the year, the one-year open lable extension study...") that he is picking out something from the OLE study. He mentions that they are "now looking at" a number of things using the CR system battery. He then says "I like to highlight especially the quality of episodic memory for a reason - we noticed that the placebo arm declined,...,in the medium stopped the decline..., but the high dose group was above baseline." No, I don't think he meant every patient in each group, but the reasonable interpretation is the average score for the patients in each group - at least that is my interpretation.

BTW, as others have, I wish to thank you for providing the excellent transcript.